Seeking Alpha
View as an RSS Feed

Bleecker Street Research  

View Bleecker Street Research's Articles BY TICKER:
  • American Addiction Centers: Addicted To Fraudulent Drug Testing?
    Editors' Pick • Tue, Mar. 3 AAC 28 Comments

    Summary

    • According to channel checks, AAC performs urine drug tests 6-12x more than necessary, contributing to outsized margins.
    • AAC is already subject to a lawsuit in New Jersey brought by Blue Cross Blue Shield alleging fraudulent drug testing.
    • In Florida, where AAC has 51% of their total beds, the FBI has begun raiding addiction centers that appear to be engaging in similar activities as AAC.
    • AAC acquired a revenue management company from the CEO and president's spouses and then lowered their provision for doubtful accounts, boosting net income before the IPO.
    • A large lock-up will come free at the end of March in four weeks, resulting in the float quadrupling and likely weighing on the share price.
  • Cellceutix: Why An Uplisting Is Not Possible Right Now
    Fri, Feb. 6 CTIX 59 Comments

    Summary

    • Cellceutix has been saying it will uplist to a major exchange for almost two years.
    • The company does not meet the Corporate Governance requirements to uplist.
    • CTIX admits in its 10-K that it will be "extremely difficult" for it to do the things required for an uplisting.
  • Cellceutix: A December To Remember May Turn Into A 2015 To Forget For CTIX
    Editors' Pick • Fri, Jan. 23 CTIX 109 Comments

    Summary

    • CTIX has made numerous misleading statements in the past.
    • CTIX has been promoted by an unregulated Swedish entity.
    • CTIX is burning around $5M cash per quarter and only has $7M in cash on hand from the most recent quarter.
  • NeoStem: Changing The Goalposts Midgame And A Potentially Biased Analyst
    Nov. 21, 2014 NBS 43 Comments

    Summary

    • NBS recently ran-up in front of expected Phase 2 data.
    • NBS failed its primary endpoint, but changed the endpoint mid-trial.
    • Maxim analyst Jason Kolbert who has a buy on the stock was previously employed by NBS and may own shares.
  • Vimicro: Numerous Red Flags Make This A Strong Sell
       • Oct. 8, 2014 VIMC 19 Comments

    Summary

    • VIMC share price has risen over 200% because of misleading press releases.
    • VIMC management has $.19 options which vest in the coming weeks.
    • VIMC management has been registering millions of dollars worth of stock to sell.
    • Numerous other red flags covered in the article.
  • China Finance Online: This Did Not End Well Last Time
    Aug. 28, 2014 JRJC 38 Comments

    Summary

    • This is not the first time JRJC has gone up on the news of a partnership.
    • In October 2007 the stock traded almost exactly the same, and the stock declined substantially after that.
    • The stock is trading similar to PLUG in March, and that stock has declined almost 50% since then.
    • If history is correct, then JRJC would have already pre-announced earnings if they were positive.
  • China Finance Online: Shares Soar On Over-Hyped Deal, More Questions Than Answers
    Editors' Pick • Aug. 20, 2014 JRJC 39 Comments

    Summary

    • JRJC recently had an announcement that sent shares soaring.
    • JRJC claims to be the first web-based security, however, Tencent has beat JRJC to the punch.
    • JRJC's conference call was light on details about the platform, and management was unable to answer basic questions.
  • Galectin Therapeutics: Why This Penny Stock Dressed Up By Stock Promoters Is A Short
    Jul. 28, 2014 GALT 56 Comments

    Summary

    • GALT has strong ties to multiple stock promoters.
    • Insiders have been selling the stock in the midst of a campaign to promote the stock to retail investors and retirees.
    • Since becoming GALT in 2011, GALT has never spent more on R&D than on G&A.
  • China XD Plastics: When The Numbers Don't Add Up, There's Over 80% Downside
    Jul. 10, 2014 CXDC 270 Comments

    Summary

    • CXDC reports substantially margins higher than its main competitor, yet spends much less on R&D.
  • Bulls Should Open Their Eyes And See The Real GlassesOff
    Jul. 3, 2014 GLSO 15 Comments

    Summary

    • GlassesOff is an intriguing concept, but expectations are currently too high.
    • With revenue of only $29k against a $70 million market cap, GlassesOff is an attractive short.
    • GlassesOff will have trouble growing revenue, since its product is going up in price and there are cheaper options.
  • Research Frontiers: Shares Could Fall Substantially If Sky-High Expectations Are Not Met
       • Jun. 20, 2014 REFR 173 Comments

    Summary

    • Research Frontiers has a long history of failing to deliver.
    • Since 2001 Research Frontiers has issued more shares than generated dollars in revenue.
    • Shares could fall 75%-95% if expectations are not met.
  • Promoted Viggle Is A Short: Why Shares Could Fall Over 60%
    Jun. 3, 2014 VGGL 37 Comments

    Summary

    • Viggle has been promoted by Small Cap Street, which also promoted PVCT.
    • Viggle user growth is already slowing, and it is disclosing fewer engagement metrics.
    • Viggle lost $96 Million in 2012 and lost $92 million in 2013. It will have difficulty turning this around.
    • CEO Sillerman's track record with publicly traded companies is poor.
    • There is currently 40-66% downside in Viggle shares, and it is an attractive short.
  • LiveDeal: Up 100% Today, But Running Out Of Tricks
    May. 23, 2014 LIVE 87 Comments

    Summary

    • LiveDeal is up 100% today (Friday).
    • This follows a bullish press release after announcing a dilutive secondary.
    • CEO Jon Isaac sounds less bullish now than he did before.
  • Why Retrophin Makes Me Uncomfortable
    Apr. 9, 2014 RTRX 62 Comments

    Summary

    • RTRX is a biotech company led by CEO Martin Shkreli.
    • It is an M&A focused company that relies on a high stock price to do deals.
    • While the strategy may suceed, there are numerous risks.
  • LiveDeal: 75% Downside This Time, The Thesis Is The Same
    Feb. 26, 2014 LIVE 41 Comments
  • LiveDeal.com Is Not Generating Any Revenue
    Feb. 14, 2014 LIVE 122 Comments
  • LiveDeal: Are Restaurants Actually Using It? And Other New Information
    Jan. 30, 2014 LIVE 98 Comments
  • LiveDeal: 50% Downside Possible In This Promoted Stock
    Jan. 28, 2014 LIVE 71 Comments
  • Puget Technologies: It's Not A 3D Printing Stock
    Jan. 16, 2014 PUGE 31 Comments
  • A Comprehensive Review Of Pizza Inn
       • Dec. 22, 2013 RAVE 11 Comments
  • Zero Hedge Is Wrong About Gold
    Dec. 17, 2013 SLV, GDXJ, GLD 200 Comments
  • Nutranomics: CEO Resume Issues And A Promoted Stock That Will Crash
       • Dec. 10, 2013 NNRX 31 Comments
  • China Nepstar: Now Is The Time To Buy, Upside Ahead
    Dec. 5, 2013 NPD 18 Comments
  • China Information Technology: Numerous Red Flags Surround This Company
       • Nov. 14, 2013 CNIT 2 Comments
  • Pricing Is The Problem At Panera
    Oct. 24, 2013 PNRA 1 Comment
  • Misunderstood Business And Red Flags Make RealBiz Media A Short
       • Oct. 23, 2013 RBIZ 7 Comments
  • Ku6 Media: A Potentially Lucrative Chinese Media Play
    Oct. 18, 2013 KUTV 13 Comments
  • VisionChina Media: No Fundamental Reason For This Rally
       • Oct. 14, 2013 VISN 36 Comments
  • China Sunergy - Gravity Will Eventually Return After This Run-Up
       • Oct. 1, 2013 CSUN 18 Comments
  • FAB Universal: This Could Be A Fad
    Editors' Pick • Sep. 26, 2013 FU 30 Comments
  • China HGS Real Estate: Potentially A Chinese House Of Cards
       • Sep. 23, 2013 HGSH 14 Comments
  • Virtual Piggy: An Intriguing Idea But Running Out Of Time To Execute
       • Sep. 8, 2013 VPIG 3 Comments